Subscribe to RSS
DOI: 10.1055/s-2008-1034357
© Georg Thieme Verlag KG Stuttgart · New York
Isolation and Biological Activities of Termilignan B and Arjunic Acid from Terminalia sericea Roots
Publication History
Received: August 28, 2007
Revised: January 29, 2008
Accepted: February 10, 2008
Publication Date:
14 March 2008 (online)
Abstract
Bioassay-guided fractionation of ethyl acetate root extracts of Terminalia sericea yielded a new compound, termilignan B, and the known arjunic acid. Both compounds showed activity against Gram-positive and Gram-negative bacteria with MIC values ranging between 1.9 and 15.6 μg/mL. The lowest MIC value (1.9 μg/mL) was observed with termilignan B against Bacillus subtilis. Neither of the compounds showed significant activity against Mycobacterium aurum A+. In the cyclooxygenase assays, the compounds showed weak inhibitory activity with IC50 values of 78 μM (COX-1) and 156 μM (COX-2) (termilignan B) and 36 μM (COX-1) and 253 μM (COX-2) (arjunic acid). No potential mutagenic effects were observed with the two compounds in the Salmonella microsome assay (TA 98).
Abbreviations
COX: cyclooxygenase
Key words
Terminalia sericea - Combretaceae - termilignan B - arjunic acid - antimicrobial - anti-inflammatory
References
- 1 Moshi M J, Mbwambo Z. Some pharmacological properties of extracts of Terminalia sericea roots. J Ethnopharmacol. 2005; 97 43-7
- 2 Neuwinger H D. African ethnobotany: poisons and drugs: chemistry, pharmacology, toxicology. London; Chapman and Hall 1996: 941
- 3 Tshikalange T E, Meyer J JM, Hussein A A. Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J Ethnopharmacol. 2005; 96 515-9
- 4 Eldeen I MS, Elgorashi E E, Mulholland D A, Van Staden J. Anolignan B: A bioactive compound from the roots of Terminalia sericea. . J Ethnopharmacol. 2006; 103 135-8
- 5 Rimando A M, Pezzuto J M, Farnsworth N R. New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod. 1994; 57 896-904
- 6 Valsaraj R, Pushpangadan P, Smitt U W, Andersen A, Christensen S B, Sittie A. et al . New anti HIV-1, antimalarial and antifungal compounds from Terminalia bellerica. . J Nat Prod. 1997; 60 739-42
- 7 Row L R, Murty P S, Subbarao G SR, Sastry C SP, Rao K VJ. Chemical examination of Terminalia species: part XII - Isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Indian J Chem. 1970; 8 716-21
- 8 Anjaneyulu A SR, Rama Prasad A V. Chemical examination of the roots of Terminalia arjuna - the structures of arjunoside III and arjunoside IV, two new triterpenoid glycosides. Phytochemistry. 1982; 21 2057-60
- 9 Maron D M, Ames B N. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983; 113 173-215
- 10 Juang L -J, Sheu S -J. Chemical identification of tannin-related constituents of Terminalia chebula. . Phytochem Anal. 2005; 16 246-51
- 11 Rios J L, Recio M C, Villar A. Screening methods for natural products with antimicrobial activity: A review of the literature. J Ethnopharmacol. 1988; 23 127-49
- 12 Eloff J N. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998; 64 711-3
- 13 Swenson J M, Thornsberry C, Silvcox V A. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by microdilution. Antimicrob Agents Chemother. 1982; 22 186-92
- 14 Eldeen I MS, Van Staden J. Antimycobacterial activity of some trees used in South African traditional medicine. S Afr J Bot. 2007; 73 248-51
- 15 Jäger A K, Hutchings A, Van Staden J. Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors. J Ethnopharmacol. 1996; 52 95-100
- 16 Noreen Y, Ringbom T, Perera P, Danielson H, Bohlin L. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod. 1998; 61 2-7
- 17 Zschocke S, Van Staden J. Cryptocarya species - substitute plants for Ocotea bullata? A pharmacological investigation in terms of cyclooxygenase-1 and -2 inhibition. J Ethnopharmacol. 2000; 71 473-8
Professor J. Van Staden
Research Centre for Plant Growth and Development
School of Biological and Conservation Sciences
University of KwaZulu-Natal Pietermaritzburg
Private Bag X01
Scottsville 3209
South Africa
Phone: +27-(0)33-260-5130
Fax: +27-(0)33-260-5897
Email: rcpgd@ukzn.ac.za